• Nissen, who is now the interim chair of cardiology at the Cleveland Clinic and president of the American College of Cardiology, has been at the forefront of doing studies for new heart drugs like AstraZeneca 's Crestor and the new "good cholesterol" drugs being developed by Pfizer.

    FORBES: Magazine Article

  • Steven Nissen, the chairman of cardiology at the Cleveland Clinic and head of the American College of Cardiology, will present one key study that will use ultrasound probes to measure the effect of torcetrapib on plaque in the coronary arteries at the ACC meeting in New Orleans next March.

    FORBES: Magazine Article

  • Nissen, who is now the interim chair of cardiology at the Cleveland Clinic and president of the American College of Cardiology, has been at the forefront of doing studies for new heart drugs like AstraZeneca 's (nyse: AZN - news - people ) Crestor and the new "good cholesterol" drugs being developed by Pfizer (nyse: PFE - news - people ).

    FORBES: Cardiac Critic

  • Steven Nissen, chairman of cardiology at the Cleveland Clinic, says he is very worried about diclofenac.

    FORBES: Is Naproxen The Only Safe Painkiller?

  • "It's really the next generation, " says Steven Nissen , vice-chairman of cardiology at the Cleveland Clinic.

    FORBES

  • The meeting was also a victory for Steven Nissen, the controversial head of cardiology at the Cleveland Clinic.

    FORBES: The Great Drug Debate

  • But most of the claims "are completely unsubstantiated, " says Steven Nissen, head of cardiology at the Cleveland Clinic.

    FORBES: Magazine Article

  • "I do not think a DSMB for ENHANCE was necessary, " says Steven Nissen, head of cardiology at the Cleveland Clinic.

    FORBES: Magazine Article

  • "It shouldn't have had to be me" that did the analysis, says Nissen, chief of cardiology at the Cleveland Clinic.

    FORBES: Lynch 'Em

  • Steven Nissen, chairman of cardiology at the Cleveland Clinic, performed the analysis by combing through 42 already completed studies of Avandia.

    FORBES: Glaxo's Drug Disaster?

  • Clinical trials "don't get any weightier, " said Steven Nissen, chairman of cardiology at the Cleveland Clinic and president of the ACC.

    FORBES: Magazine Article

  • Monday morning the New England Journal of Medicine released a study by Steven Nissen, chairman of cardiology at the Cleveland Clinic.

    FORBES: Magazine Article

  • "Physicians should only use ezetimibe or Vytorin as a last resort, " Steven Nissen, head of cardiology at the Cleveland Clinic, said Monday.

    FORBES: Vytorin Study Shows No Benefit

  • "It's sad news, " says Steven Nissen, chairman of cardiology at the Cleveland Clinic and one of the researchers who has been studying the drug.

    FORBES: Magazine Article

  • The biggest similarity is that like ENHANCE, CASHMERE should have been published a lot earlier, says Steven Nissen, head of cardiology at the Cleveland Clinic.

    FORBES: The Vytorin Stretch

  • Steven Nissen, chairman of cardiology at the Cleveland Clinic and a Vytorin critic, says that he thinks the rush to release the information was improper.

    FORBES: Magazine Article

  • Eric Topol, chairman of cardiology at the Cleveland Clinic, is planning a second trial to see if Acomplia prevents heart attacks, strokes and deaths in heart patients.

    FORBES: The Ultimate Pill?

  • Steven Nissen, chairman of cardiology at the Cleveland Clinic, says that he "does not agree with the interpretation" that the data from MEDAL shows no cardiovascular risk for Arcoxia.

    FORBES: Magazine Article

  • Suggesting the cancer trials were cardiovascular tests is misleading and inappropriate, says Richard Milani , vice chairman of the department of cardiology at the Ochsner Clinic in New Orleans.

    FORBES: Merck's Missing Vioxx Study

  • "I think we made it very clear that none of us could support off-label use, " says Steven Nissen, head of cardiology at the Cleveland Clinic and a member of the panel.

    FORBES: Dangerous Ignorance

  • "Getting rid of that plaque is a fundamental step in stopping this disease, " says Steven Nissen, interim chairman of cardiology at the Cleveland Clinic and lead author of the study, called Asteroid.

    FORBES: Crestor Cleans Up

  • "The new APC trial confirms that the safety issue--heart attack and stroke risk---is one that applies to the whole class of Cox-2 inhibitors, " says Eric Topol , chairman of cardiology at the Cleveland Clinic.

    FORBES: Pfizer's Heart Attack

  • Eric Topol, chairman of cardiology at the Cleveland Clinic and one of the most vocal critics of Bextra and Vioxx, says that he saw the FDA panel split mostly between arthritis doctors and others.

    FORBES: Doctors Back Bextra Ban

  • Eric Topol , one of the country's most well-known doctors and a pivotal figure in the Vioxx litigation, may leave his post as chairman of cardiology at the Cleveland Clinic, according to a Merck spokesman.

    FORBES: Magazine Article

  • "By combining them at a single tablet and offering them at a single price, you obviously create a benefit to the patient, " says Richard Milani head of cardiology at the Ochsner Clinic in New Orleans.

    FORBES: FDA Approves Potential Cholesterol Blockbuster

  • It analyzed data from studies conducted by Steven Nissen, head of cardiology at the Cleveland Clinic, that used tiny ultrasound probes to measure the buildup of plaque in patients who were taking common cholesterol-lowering drugs called statins: Pravachol, Lipitor and Crestor.

    FORBES: Magazine Article

  • Both Stein and Steven Nissen, interim chairman of cardiology at the Cleveland Clinic, say they are worried that the drug will be pushed for patients who have had recent heart attacks and suffer from chest pain, where the data back a higher-powered drug.

    FORBES: The Generic Onslaught

  • Steven Nissen, the chairman of cardiology at the Cleveland Clinic, who is known partly for his criticism of Merck's (nyse: MRK - news - people ) Vioxx and other drugs, says he thinks stents should not be employed for unapproved uses.

    FORBES: Stents, Smoke And Fire

  • "The right approach to public health is to say it's incumbent on any new drug to show it is beneficial and has acceptable risk, " says Steven Nissen, head of cardiology at the Cleveland Clinic and one of the first to note the excesses in cancer death.

    FORBES: The Vytorin Saga

  • Among the doubters is Eric Topol , the chairman of cardiology at the Cleveland Clinic and one of the most vocal critics of Merck 's (nyse: MRK - news - people ) Vioxx, which, like Celebrex, belongs to a class of drugs called Cox-2 inhibitors.

    FORBES: The Celebrex Safety Mirage

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定